Qiming’s Leung: COVID-19 response displays the deep networks of China’s biotech ecosystem: a BioCentury audio interview

The picture Nisa Leung, managing director of Qiming Venture Partners, paints of the response among Chinese biotechs to COVID-19 is one that underscores how the local ecosystem has matured from a “budding” one to a highly dynamic, integrated scene, with biotech CEOs and healthcare providers in close communication.

On an audio interview for BioCentury’s Back to School — part of a series of interviews with key industry leaders — Leung expanded on the difference in China between this outbreak and what she witnessed early in her career with the SARS 2003 response (see Cover Story: “Back to School 2020”)...